As per Roots Analysis, most of
the viral vector and gene therapy manufacturers (66%) are located in North
America, followed by the players headquartered in Eu
Given the multifaceted advantages of antisense oligonucleotide therapeutics, the field has witnessed an increase in
the number of players involved in the devel
During our research, we came across 32 industry players that
are presently engaged in the development of digital solutions for biomarkers. Most of the develope
Since Martin Cline’s initial attempts at modifying human DNA
to cure thalassemia in 1980, a number of genetically modified therapies have
been / are being inv
Oligonucleotides (commonly referred to as oligos),
are short single stranded DNA or RNA molecules, typically containing 15-20
nucleotide residues. In the mode
In general, biomarkers or biological markers are defined as
distinctive physiological features in an individual, which can be detected and
quantified in order
Brand positioning analysis of the key industry players helps to develop an understanding on how the brands of companies are currently perceived / positioned in
Competitive benchmark analysis allows the companies
to compare their existing capabilities within their respective peer groups (based
on company size and loca
Over the last decade, there has been a change in the nature of outsourcing relationships. Associations between sponsor companies and service providers have evol
Technical
advances and innovation in design within the medical devices industry have
prompted regulatory authorities to update the laws governing various aspe
During our research, we were able to
identify over 250 industry players that presently claim to offer contract
services for clinical development of medical de
With increasing cases of drug
failure, due to problems associated with pharmacokinetic profiles of candidate
therapies, absorption, distribution,
metabol
Liquid biopsies have emerged as a
versatile diagnostic solution, especially for cases when conventional
(invasive) diagnostic tests are inconclusive or when t
Numerous scientific and technological breakthroughs in the medical device industry, over the past decade, have resulted in an accelerated pace of research and i